메뉴 건너뛰기




Volumn 41, Issue 3, 1997, Pages 535-539

Reversible fluconazole resistance in Candida albicans: A potential in vitro model

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

EID: 0031038192     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.3.535     Document Type: Article
Times cited : (55)

References (27)
  • 1
    • 0015149959 scopus 로고
    • The development of resistance by Candida species to polyene antibiotics in vitro
    • Athar, M. A., and H. I. Winner. 1971. The development of resistance by Candida species to polyene antibiotics in vitro. J. Med. Microbiol. 4:505-517.
    • (1971) J. Med. Microbiol. , vol.4 , pp. 505-517
    • Athar, M.A.1    Winner, H.I.2
  • 2
    • 0028275770 scopus 로고
    • Fluconazole-resistant candidosis in an HIV cohort
    • Baily, G. G., F. M. Perry, D. W. Denning, and B. K. Mandal. 1994. Fluconazole-resistant candidosis in an HIV cohort. AIDS 8:787-792.
    • (1994) AIDS , vol.8 , pp. 787-792
    • Baily, G.G.1    Perry, F.M.2    Denning, D.W.3    Mandal, B.K.4
  • 3
    • 0028031854 scopus 로고
    • Genotypic variation and slime production among blood isolates and catheter isolates of Candida parapsilosis
    • Branchini, M. L., M. A. Pfaller, J. Rhine-Chalberg, T. Frempong, and H. D. Isenberg. 1994. Genotypic variation and slime production among blood isolates and catheter isolates of Candida parapsilosis. J. Clin. Microbiol. 32:452-456.
    • (1994) J. Clin. Microbiol. , vol.32 , pp. 452-456
    • Branchini, M.L.1    Pfaller, M.A.2    Rhine-Chalberg, J.3    Frempong, T.4    Isenberg, H.D.5
  • 4
    • 0026709144 scopus 로고
    • Antifungal chemotherapy in patients with acquired immunodeficiency syndrome
    • British Society for Antimicrobial Chemotherapy Working Party. 1992. Antifungal chemotherapy in patients with acquired immunodeficiency syndrome. Lancet 340:648-651.
    • (1992) Lancet , vol.340 , pp. 648-651
  • 5
    • 0027360244 scopus 로고
    • Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1
    • Cameron, M., W. A. Schell, S. Bruch, J. A. Bartlett, H. A. Waskin, and J. R. Perfect. 1993. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 37: 2449-2453.
    • (1993) Antimicrob. Agents Chemother. , vol.37 , pp. 2449-2453
    • Cameron, M.1    Schell, W.A.2    Bruch, S.3    Bartlett, J.A.4    Waskin, H.A.5    Perfect, J.R.6
  • 6
    • 0028228471 scopus 로고
    • Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients
    • Chavanet, P., J. Lopez, M. Grappin, A. Bonnin, M. Duong, A. Waldner, M. Buisson, P. Camerlynck, and H. Portier. 1994. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS 8:945-950.
    • (1994) AIDS , vol.8 , pp. 945-950
    • Chavanet, P.1    Lopez, J.2    Grappin, M.3    Bonnin, A.4    Duong, M.5    Waldner, A.6    Buisson, M.7    Camerlynck, P.8    Portier, H.9
  • 8
    • 0028068809 scopus 로고
    • Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus
    • He, X., R. N. Tiballi, L. T. Zarins, S. F. Bradley, J. A. Sangeorzan, and C. A. Kauffman. 1994. Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 38:2495-2497.
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 2495-2497
    • He, X.1    Tiballi, R.N.2    Zarins, L.T.3    Bradley, S.F.4    Sangeorzan, J.A.5    Kauffman, C.A.6
  • 10
    • 84907123977 scopus 로고
    • The lipid composition and permeability to azole of an azole- and polyene-resistant mutant of C. albicans
    • Hitchcock, C. A., K. J. Barrett-Bee, and N. J. Russell. 1987. The lipid composition and permeability to azole of an azole-and polyene-resistant mutant of C. albicans. J. Med. Vet. Mycol. 25:29-37.
    • (1987) J. Med. Vet. Mycol. , vol.25 , pp. 29-37
    • Hitchcock, C.A.1    Barrett-Bee, K.J.2    Russell, N.J.3
  • 11
    • 0015463020 scopus 로고
    • Laboratory assessment of the antimycotic drug clotrimazole
    • Holt, R. J., and R. L. Newman. 1972. Laboratory assessment of the antimycotic drug clotrimazole. J. Clin. Pathol. 25:1089-1097.
    • (1972) J. Clin. Pathol. , vol.25 , pp. 1089-1097
    • Holt, R.J.1    Newman, R.L.2
  • 12
    • 0026788125 scopus 로고
    • Drug resistance in human pathogenic fungi
    • Iwata, K. 1992. Drug resistance in human pathogenic fungi. Eur. J. Epidemiol. 8:407-421.
    • (1992) Eur. J. Epidemiol. , vol.8 , pp. 407-421
    • Iwata, K.1
  • 13
    • 0028927789 scopus 로고
    • Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis
    • Johnson, E. M., D. W. Warnock, J. Luker, S. R. Porter, and C. Scully. 1995. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J. Antimicrob. Chemother. 35:103-114.
    • (1995) J. Antimicrob. Chemother. , vol.35 , pp. 103-114
    • Johnson, E.M.1    Warnock, D.W.2    Luker, J.3    Porter, S.R.4    Scully, C.5
  • 14
    • 0001889930 scopus 로고
    • Molecular studies on azole sensitivity in fungi
    • B. Maresca, G. S. Kobayashi, and H. Yamaguchi (ed.), NATO ASI Sciences, Springer-Verlag, Berlin, Germany
    • Kelly, S. L., and D. E. Kelly. 1993. Molecular studies on azole sensitivity in fungi, p. 200-213. In B. Maresca, G. S. Kobayashi, and H. Yamaguchi (ed.), Molecular biology and its application to medical mycology. NATO ASI Sciences, Springer-Verlag, Berlin, Germany.
    • (1993) Molecular Biology and Its Application to Medical Mycology , pp. 200-213
    • Kelly, S.L.1    Kelly, D.E.2
  • 15
    • 0028942449 scopus 로고
    • Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylegosta-8,24 (28)-dien-3 beta, 6 alpha-diol
    • Kelly, S. L., D. C. Lamb, A. J. Corran, B. C. Baldwin, and D. E. Kelly. 1995. Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylegosta-8,24 (28)-dien-3 beta, 6 alpha-diol. Biochem. Biophys. Res. Commun. 207:910-915.
    • (1995) Biochem. Biophys. Res. Commun. , vol.207 , pp. 910-915
    • Kelly, S.L.1    Lamb, D.C.2    Corran, A.J.3    Baldwin, B.C.4    Kelly, D.E.5
  • 16
    • 0020531931 scopus 로고
    • Evidence for an intron-containing sequence of the splicing of yeast RNA polymerase II transcripts
    • Langford, C. J., and D. Gallwitz. 1983. Evidence for an intron-containing sequence of the splicing of yeast RNA polymerase II transcripts. Cell 33: 519-527.
    • (1983) Cell , vol.33 , pp. 519-527
    • Langford, C.J.1    Gallwitz, D.2
  • 17
    • 0028324030 scopus 로고
    • Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: Persistence of Candida albicans strains with the same genotype
    • Millon, L., A. Manteaux, G. Reboux, C. Drobacheff, M. Monod, T. Barale, and Y. Michel-Briand. 1944. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J. Clin. Microbiol. 32:1115-1118.
    • (1944) J. Clin. Microbiol. , vol.32 , pp. 1115-1118
    • Millon, L.1    Manteaux, A.2    Reboux, G.3    Drobacheff, C.4    Monod, M.5    Barale, T.6    Michel-Briand, Y.7
  • 18
    • 0027159764 scopus 로고
    • Resistance of yeasts to azole-derivative antifungals
    • Odds, F. C. 1993. Resistance of yeasts to azole-derivative antifungals. J. Antimicrob. Chemother. 31:463-471.
    • (1993) J. Antimicrob. Chemother. , vol.31 , pp. 463-471
    • Odds, F.C.1
  • 19
    • 0028817337 scopus 로고
    • Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia
    • Rex, J. H., M. A. Pfaller, A. L. Barry, P. W. Nelson, and C. D. Webb. 1995. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob. Agents Chemother. 39:40-44.
    • (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 40-44
    • Rex, J.H.1    Pfaller, M.A.2    Barry, A.L.3    Nelson, P.W.4    Webb, C.D.5
  • 20
    • 0027993041 scopus 로고
    • Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance
    • Sangeorzan, J. A., S. F. Bradley, X. He, L. T. Zarins, G. L. Ridenour, R. N. Tiballi, and C. A. Kauffman. 1994. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am. J. Med. 97:339-346.
    • (1994) Am. J. Med. , vol.97 , pp. 339-346
    • Sangeorzan, J.A.1    Bradley, S.F.2    He, X.3    Zarins, L.T.4    Ridenour, G.L.5    Tiballi, R.N.6    Kauffman, C.A.7
  • 21
    • 0028793725 scopus 로고
    • Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
    • Sanglard, D., K. Kuchler, F. Ischer, J.-L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
    • (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 2378-2386
    • Sanglard, D.1    Kuchler, K.2    Ischer, F.3    Pagani, J.-L.4    Monod, M.5    Bille, J.6
  • 24
    • 0028294846 scopus 로고
    • Investigation of the sequence of colonization and candidemia in nonneutropenic patients
    • Voss, A., R. J. Hollis, M. A. Pfaller, R. P. Wenzel, and B. N. Doebbeling. 1994. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J. Clin. Microbiol. 32:975-980.
    • (1994) J. Clin. Microbiol. , vol.32 , pp. 975-980
    • Voss, A.1    Hollis, R.J.2    Pfaller, M.A.3    Wenzel, R.P.4    Doebbeling, B.N.5
  • 25
    • 0343779152 scopus 로고
    • Overexpression and point mutations in lanosterol 14α demethylase associated with fluconazole resistance in C. albicans
    • abstr. C103, American Society for Microbiology, Washington, D.C.
    • White, T. C. 1995. Overexpression and point mutations in lanosterol 14α demethylase associated with fluconazole resistance in C. albicans, abstr. C103, p. 58. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
    • (1995) Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 58
    • White, T.C.1
  • 26
    • 0342908318 scopus 로고    scopus 로고
    • Azole drug resistance in a series of Candida albicans isolates is the result of several genomic alterations
    • abstr. B40. American Society for Microbiology, Washington, D.C.
    • White, T. C. 1996. Azole drug resistance in a series of Candida albicans isolates is the result of several genomic alterations, abstr. B40. In Program and abstracts of the ASM Conference on Candida and Candidiasis: Biology, Pathogenesis, and Management. American Society for Microbiology, Washington, D.C.
    • (1996) Program and Abstracts of the ASM Conference on Candida and Candidiasis: Biology, Pathogenesis, and Management
    • White, T.C.1
  • 27
    • 0025930637 scopus 로고
    • Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis
    • Witt, M. W., and A. S. Bayer. 1991. Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis. Antimicrob. Agents Chemother. 35:2481-2485.
    • (1991) Antimicrob. Agents Chemother. , vol.35 , pp. 2481-2485
    • Witt, M.W.1    Bayer, A.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.